Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	291.13	145.96	-37.32
Graham Fair Price	-87.01	5.04	38.79
PEG	15309121968.54	2.82	< 0.005
Price/Book	20.36	0.57	0.47
Price/Cash Flow	704.49	-109.69	13.64
Prices/Earnings	6879.05	286.56	-4.11
Price/Sales	55.94	91.12	58.43
Price/FCF	704.49	-109.69	13.64
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	-89.45	< 0.005	-0.02
ROE	-0.03	< 0.005	-98.28
ROIC	0.00	0.00	0.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.60	99.34
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.00	0.00	inf
EPS QOQ	-2225144.63	1.01	-100.00
FCF QOQ	0.34	-1.15	237.01
Revenue QOQ	93845508.93	-0.24	-100.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	92.70	29.01	-68.70
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.43	0.43	0.35
Quick Ratio	0.20	0.04	-81.92
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	48.15	47.64	-1.08
Cash	2.78	2.92	5.30
Capex	0.00	0.00	0.00
Free Cash Flow	1.67	-0.25	-85.20
Revenue	0.39	0.30	-23.64
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.00	0.04	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-22.28	80.60	261.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating